Last updated: August 2026
Home › Blog › NMN Dosage Guide UK 2026
⚠️ Educational content only. NMN is a food supplement — not a medicine. No authorised EU/UK health claims exist for NMN. All dosage information on this page is general educational information based on published research literature — not personalised medical advice and not health claims for any product. Always consult your GP before starting any supplement regimen.
How much NMN should you take? It is the first question everyone asks — and one the supplement industry rarely answers with appropriate context. This guide covers what published human clinical trial literature discusses in relation to NMN dosage by age group. It is general educational information only — not personalised medical advice and not health claims for any product.
A number of published human clinical trials have examined NMN at various doses in adults of different ages. The dosage information below is drawn from the general patterns discussed across this literature. We have linked the published papers in the references section below so you can read the actual research for yourself — we are not stating what those trials found as a benefit of our products.
For a broader overview of NMN including UK legal status, purity testing and the difference between NMN and NR, see our companion guide: Top 10 NMN Questions Answered UK 2026 →
Why Age Is Relevant to NMN Dosage
NAD+ is a coenzyme present in every cell in the human body. Published biology has established that NAD+ levels decline with age — this is a well-documented biological fact, not a marketing claim. The degree of that decline, and what it means for supplementation, is what the clinical trial literature explores.
The general pattern discussed across published NMN trials is that age appears to be a relevant factor in dosage — older adults have been examined at higher doses in research contexts than younger adults. This is the basis for the age-based dosage information below. It is general information — not a statement that NMN will produce any specific outcome at any dose.
WHAT TO TAKE ALONGSIDE NMN — PUBLISHED CO-FACTOR CONTEXT
This is a question raised frequently by researchers and informed supplementers. Three co-factors appear most consistently in the published NMN literature and broader NAD+ biology discussion. General educational information only — not health claims. Food supplement — not a medicine.
1. TMG (Trimethylglycine / Betaine) — The Methyl Donor
This is the most clinically discussed co-factor alongside NMN. The rationale is grounded in methylation biochemistry: NMN raises NAD+ via the Preiss-Handler pathway — a process that consumes methyl groups. TMG (trimethylglycine) is a methyl donor. It donates methyl groups in the one-carbon cycle and may help offset the methyl demand created by sustained NMN supplementation.
This is a pharmacological rationale discussed in the published methylation biology literature — not a health claim. Published researchers including those associated with the Sinclair Lab at Harvard have discussed TMG as a practical co-supplementation consideration alongside NMN in research and public education contexts.
Educational context only — not a product claim. Food supplement — not a medicine.
2. Trans-Resveratrol — The SIRT1 Intersection
Resveratrol is one of the most studied SIRT1 activators in published biology. SIRT1 is a NAD+-dependent deacetylase — it requires NAD+ as its substrate to function. The mechanistic logic discussed in published research: NMN raises NAD+ → more substrate is available for SIRT1 → resveratrol may activate SIRT1 more effectively in the presence of adequate NAD+. This intersection is frequently cited in published longevity biology and was central to early NMN research in Sinclair et al. mouse model studies.
Educational context only — not a health claim. No combined human RCT has directly tested this pairing. Food supplement — not a medicine. We offer an NMN + Resveratrol 500mg capsule for those who prefer a combined format.
3. Magnesium — Mitochondrial Cofactor
Magnesium is a cofactor in over 300 enzymatic reactions, including those involved in ATP synthesis and DNA repair pathways. Published biology describes magnesium as essential for mitochondrial function. Magnesium Glycinate has 9 authorised EU/UK health claims — the only supplement discussed on this page for which authorised claims exist — including contributions to normal energy-yielding metabolism and normal functioning of the nervous system.
The 9 authorised claims are for magnesium specifically — not for NMN. Food supplement — not a medicine.
None of the above constitutes a health claim for any product. The rationale for each co-factor is drawn from published biochemistry and pharmacology literature. Always consult your GP before combining supplements. Food supplement — not a medicine.
NMN Dosage by Age — General Information
Based on published human clinical trial literature. General information only — not personalised medical advice. Consult your GP before starting. Food supplement — not a medicine.
Quick Reference — General Information Only
General information based on published trial literature. Not personalised medical advice. Not health claims. Consult your GP.
| Age Group | General Dose in Literature | Published Papers | Our Products |
|---|---|---|---|
| Under 40 | 250mg/day | Yoshino et al. (2021) · Irie et al. (2020) | NMN 500mg → |
| 40–50 | 500mg/day | GeroScience RCT (2022) · Liao et al. (2021) | NMN 500mg → |
| 50–60 | 500–900mg/day | GeroScience RCT · Yi et al. (2023) | NMN 700mg → |
| Over 60 ⚠️ | 750–1,000mg/day | Igarashi et al. (2024) · GeroScience RCT higher arms | NMN 700mg → |
General information only. Not personalised medical advice. Not health claims for any product. Consult your GP before starting. Food supplement — not a medicine.
⚠️ IMPORTANT — DUAL CAPSULE PRODUCTS
Are You Getting the NMN Dose You Think You Are?
This is a practical labelling point worth being aware of — not a health claim. Dual NMN capsules — such as NMN + Trans-Resveratrol or NMN + CoQ10 — split the capsule contents between two active ingredients. A 500mg dual capsule typically contains:
Always check the label for the NMN content specifically — not the total capsule weight. This is particularly relevant if you are comparing your current dose against the age-based general information above.
🔬 The Case for a NAD+ Test Before You Start
NMN works at a cellular level. It does not produce effects that are typically felt subjectively — unlike caffeine or a painkiller. This means that without an objective baseline measure, it is very difficult to know whether any supplementation is having an effect at your particular dose.
A NAD+ blood test taken before starting supplementation and again after 8–12 weeks at a consistent dose gives you an objective reference point. NAD+ tests are now widely available in the UK from a number of private testing providers. Christen et al. (2025) in Nature Metabolism confirmed that NMN sustainably doubles circulating NAD+ — but the degree of individual response will vary. A baseline test is the only way to assess your personal response objectively.
Step 1
Take a NAD+ blood test before starting — establish your baseline
Step 2
Take NMN consistently at your chosen dose for 8–12 weeks
Step 3
Retest NAD+ and compare against your baseline
Members of the wider NMN community on Reddit who have tested their NAD+ levels before and after supplementing have shared their results in various community threads. We are not citing those results as evidence of product benefit — we simply note that independent testing is the only objective way to assess any supplement's effect on NAD+ levels personally.
Safety — What Has Been Published
Published human trials have examined NMN at various doses. Safety findings from those trials are a matter of public record in the published literature — we link the papers in the references below.
Irie et al. (2020) formally established safety and pharmacokinetics at single oral doses up to 500mg in a phase I human clinical trial — this is the most rigorous published safety dataset for NMN at this dose level. The most commonly noted minor effects at onset are mild and temporary gastrointestinal discomfort.
For doses above 500mg/day — particularly in adults over 60 — safety data is drawn from trial arms within broader efficacy studies rather than dedicated long-term safety trials. This is an important distinction. No serious adverse effects have been reported in published short-term human trials at doses up to 1,200mg/day, but "short-term" means 2–12 weeks in the majority of trials.
⚠️ All published human safety data is short-term (2–12 weeks). No long-term human safety data exists beyond this window. Always consult your GP before starting NMN — particularly if you are on prescription medication, have kidney disease, are pregnant or breastfeeding, or have a history of cancer. GP consultation is strongly advised for adults over 60 considering doses above 500mg/day. Food supplement — not a medicine.
OUR NMN RANGE
Food supplements — not medicines. 99.99% pure β-NMN · Eurofins tested · in-house UK encapsulation · 5 Star FSA · 161,000+ verified sales.
RELATED GUIDE
Top 10 NMN Questions Answered — UK 2026
UK legal status · human trial overview · sublingual vs capsule · NMN vs NR · purity testing · safety data — all 10 most asked NMN questions covered with published literature references.
Read the Full Guide →📚 Published Literature Referenced
Links provided so you can read the actual research. We are not stating that these papers demonstrate benefit from our products — they are provided for educational reference only.
Yoshino et al. (2021) — NMN trial in postmenopausal women · Cell Metabolism
PubMed 34015196 →Irie et al. (2020) — NMN pharmacokinetics and safety · phase I human trial · NPJ Aging
PubMed 33378646 →Liao et al. (2021) — NMN in amateur runners · Journal of the International Society of Sports Nutrition
PubMed 34514983 →GeroScience Multicenter RCT (2022) — multiple NMN doses in adults aged 40–65 · GeroScience
PubMed 35708746 →Yi et al. (2023) — NMN supplementation and physical performance in middle-aged adults · GeroScience
PubMed 36482269 →Igarashi et al. (2024) — NMN 250mg/day in adults aged 65–75 · walking speed · sleep · NAD+ restoration · GeroScience
Search: Igarashi NMN 2024 GeroScience for full citation
Christen et al. (2025) — Head-to-head NMN vs NR vs Niacin · NMN sustainably doubles circulating NAD+ · Nature Metabolism
doi:10.1038/s42255-025-01421-8 →Verdin (2015) — NAD+ in ageing and metabolism · Science
PubMed 24270807 →